Anika Therapeutics Non-GAAP EPS of -$0.06 misses by $0.15, revenue of $26.17M misses by $1.9M

Stock Information for Anika Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Anika Therapeutics Inc.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Reports First Quarter 2025 Financial Results
Anika to Participate in the Sidoti Virtual Investor Conference
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Reports Fourth Quarter and Full Year 2024 Financial Results
Anika Completes Divestiture of Parcus Medical

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.